BA
GNMK

BlackRock Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

BlackRock Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$296K Buy
24,201
+1,381
+6% +$16.4K ﹤0.01% 2507
2016
Q3 		$269K Buy
22,820
+2,106
+10% +$20.3K ﹤0.01% 2524
2016
Q2 		$180K Buy
20,714
+615
+3% +$4.22K ﹤0.01% 2666
2016
Q1 		$106K Buy
20,099
+1,033
+5% +$5.75K ﹤0.01% 2895
2015
Q4 		$148K Sell
19,066
-9,688
-34% -$74.4K ﹤0.01% 2731
2015
Q3 		$226K Buy
28,754
+564
+2% +$5.22K ﹤0.01% 2656
2015
Q2 		$255K Buy
28,190
+829
+3% +$8.36K ﹤0.01% 2660
2015
Q1 		$355K Buy
27,361
+4,083
+18% +$53.4K ﹤0.01% 2331
2014
Q4 		$317K Sell
23,278
-1,949
-8% -$21.8K ﹤0.01% 2327
2014
Q3 		$226K Sell
25,227
-332
-1% -$3.57K ﹤0.01% 2539
2014
Q2 		$346K Sell
25,559
-1,034
-4% -$10.8K ﹤0.01% 2284
2014
Q1 		$264K Buy
26,593
+2,289
+9% +$28.4K ﹤0.01% 2490
2013
Q4 		$323K Buy
24,304
+1,848
+8% +$22.4K ﹤0.01% 2351
2013
Q3 		$273K Sell
22,456
-602,054
-96% -$6.45M ﹤0.01% 2345
2013
Q2 		$6.46M Buy
+624,510
New +$8.61M 0.01% 890

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Advisors's GNMK Position: Q4 2016 in Review

BlackRock Advisors increased its GenMark Diagnostics, Inc (GNMK) stake by 6.1% in Q4 2016, buying an estimated $16.4K and bringing the position to 24,201 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #2507.

BlackRock Advisors first reported a position in GNMK in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.46M in Q2 2013. 90 funds tracked by Wall St. Rank hold GNMK as of Q4 2016.

  • BlackRock Advisors held 24,201 shares of GenMark Diagnostics, Inc worth $296K as of Q4 2016.
  • BlackRock Advisors bought 1,381 GenMark Diagnostics, Inc shares in Q4 2016, an estimated $16.4K.
  • GenMark Diagnostics, Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2507 holding.
  • BlackRock Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's GenMark Diagnostics, Inc position peaked at $6.46M in Q2 2013.
  • 90 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.